The role of hepatic encephalopathy in the era of MELD

Liver Transplantation

Volumn 13, Issue 10, 2007, Pages 1364-1365

  Thornton, Julia Gore ^a   Mullen, Kevin D ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; LACTULOSE;

DEHYDRATION; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EDITORIAL; EMPYEMA; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; PORTOSYSTEMIC ANASTOMOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PSOAS ABSCESS; SCORING SYSTEM; SURVIVAL; TREATMENT OUTCOME; VEIN THROMBOSIS;

HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; PROGNOSIS; SEVERITY OF ILLNESS INDEX; WAITING LISTS;

EID: 35448983890     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21229     Document Type: Editorial

References (16)

1. Stewart C, Malinchoc M, Kim WR, Kamath PS. Hepatic encephalopathy as a predictor of survival in patients with end stage liver disease. Liver Transpl 2007;13:1366-1371.
2. Ong JP, Aggarwal A, Krieger D, Easley KA, Karafa MT, Van Lente F, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 2003;114: 188-193.
3. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-470.
4. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004:40:897-903.
5. Scientific Registry of Transplant Recipients. Data analysis for the OPTN Liver-Intestine Committee. Richmond, VA: 2005;264-268.
6. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217-231.
7. Pappas SC, Jones EA. Methods for assessing hepatic encephalopathy. Semin Liver Dis 1983;3:298-307.
8. Ham J, Gish RG, Mullen K. Model for end-stage liver disease (MELD) exception for hepatic encephalopathy. Liver Transpl. 2006;12(Suppl 3):S102-S104.
9. Riggio O, Efrati C, Catalano C, Pediconi F, Mecarelli O, Accornero N, et al. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study. Hepatology 2005;42:1158-1165.
10. Maeda T, Mori H, Aikawa H, Komatsu E, Kagawa K. Therapeutic embolization of intrahepatic portosystemic shunts by retrograde transcaval catheterization. Cardiovasc Intervent Radiol 1993;16:245-247.
11. Moriya K, Kojima H, Matsumura M, Sakurai S, Imazu H, Uemura M, et al. Disappearance of hepatic encephalopathy and improvement of liver function after surgical treatment of portal-systemic shunt in a patient with liver cirrhosis. Hepatogastroenterology 2003;50:1128-1132.
12. Vaquero J, Oliver D, Hassanein T, Stange J, Blei AT. Evolution of mental state in a clinical trial of MARS for patients with acute hepatic encephalopathy. Comparison of two scales. In: Fallon RC, Jones EA, Meijer AJ, Chamulea R, eds. Encephalopathy and Nitrogen Metabolism in Liver. Dandreckt, The Netherlands: Kluwer Academe, 2003:55-70.
13. Kamath PS, Kim WR. The Model for End-Stage Liver Disease (MELD). Hepatology 2007;45:797-805.
14. Larson AM, Curtis JR. Integrating palliative care for liver transplant candidates: "too well for transplant, too sick for life". JAMA 2006;295:2168-2176.
15. Heyland DK, Rocker GM, Dodek PM, Kutsogiannis DJ, Konopad E, Cook DJ, et al. Family satisfaction with care in the intensive care unit: results of a multiple center study. Crit Care Med 2002;30:1413-1418.
16. White DB, Engelberg RA, Wenrich MD, Lo B, Curtis JR. Prognostication during physician-family discussions about limiting life support in intensive care units. Crit Care Med 2007;35:442-448.